Adiponectin multimers and metabolic syndrome traits: Relative adiponectin resistance in African Americans

Obesity

Volumn 16, Issue 12, 2008, Pages 2616-2623

  Lara Castro, Cristina ^a   Doud, Erin C ^a   Tapia, Patrick C ^a   Munoz, Andres J ^a   Fernandez, Jose R ^a   Hunter, Gary R ^a   Gower, Barbara A ^a   Garvey, W Timothy ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CAUCASIAN; ETHNOLOGY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MOLECULAR WEIGHT; PREMENOPAUSE;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MOLECULAR WEIGHT; PREMENOPAUSE; TRIGLYCERIDES;

EID: 58149314349     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.411     Document Type: Article

References (42)

1. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007; 18:263-270.
2. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
3. Bush NC, Darnell BE, Oster RA, Goran Ml, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005;54:2772-2778.
4. Tonelli J, Li W, Kishore P et al. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004;53:1621-1629.
5. Pajvani UB, Hawkins M, Combs TP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004;279:12152-12162.
6. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249-259.
7. Fisher FF, Trujillo ME, Hanif W et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005;48:1084-1087.
8. Bodies A, Banga A, Rasouli N et al. Pioglitazone increases secretion of high molecular weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006;291:E1100-E1105.
9. Bobbert T, Rochlitz H, Wegewitz U et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005;54:2712-2719.
10. Hammarstedt A, Sopasakis VR, Gogg S, Jansson PA, Smith U. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia 2005;48:96-104.
11. Halperin F, Beckman JA, Patti ME et al. The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes. Diabetologia 2005;48:2147-2154.
12. Sinha MK, Songer T, Xiao Q et al. Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem 2007;53:2144-2151.
13. Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352-40363.
14. Kobayashi H, Ouchi N, Kihara S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004;94:e27-e31.
15. Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 2005;46:1369-1379.
16. Schober F, Neumeler M, Weigert J et al. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007;361:968-973.
17. van der Merwe MT, Crowther NJ, Schlaphoff GP et al. Evidence for insulin resistance in black women from South Africa. Int J Obes Relat Metab Disord 2000;24:1340-1346.
18. Stein E, Kushner H, Gidding S, Falkner B. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism 2007;56:954-960.
19. Fernández JR, Shiver MD. Using genetic admixture to study the biology of obesity traits and to map genes in admixed populations. Nutr Rev 2004;62:S69-S74.
20. Gower BA, Fernández JR, Beasley TM, Shrlver MD, Goran MI. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes 2003;52:1047-1051.
21. Saad MF, Steil GM, Riad-Gabriel M et al. Method of insulin administration has no effect on insulin sensitivity estimates from the insulin-modified minimal model protocol. Diabetes 1997;46:2044-2048.
22. Welch S, Gebhart SS, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990;71:1508-1518.
23. Akey JM, Sosnoski D, Parra E et al. Melting curve analysis of SNPs (McSNP): a gel-free and inexpensive approach for SNP genotyping. Biotechniques 2001;30:358-362, 364, 366-367.
24. Higgins PB, Fernández JR, Goran MI, Gower BA. Early ethnic difference in insulin-like growth factor-1 is associated with African genetic admixture. Pediatr Res 2005;58:850-854.
25. Hanis CL, Chakraborty R, Ferrell RE, Schull WJ. Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am J Phys Anthropol 1986;70:433-441.
26. Hada Y, Yamauchi T, Waki H et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 2007;356:487-493.
27. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996;45:1119-1124.
28. Carroll JF, Chiapa AL, Rodriquez M et al. Visceral fat, waist circumference, and BMI: Impact of race/ethnicity. Obesity (Silver Spring) 2008; 16:600-607.
29. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE et al. Lower serum adiponectin levels in African-American boys. Ooes Res 2003; 11: 1384-1390.
30. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004;53:1-3.
31. Liu Y, Retnakaran R, Hanley A et al. Total and High molecular weight (HMW) but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab 2007;92:4313-4318.
32. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adponectin complexes have distinct biochemical characteristics. Endocrinology 2008;149:2270-2282.
33. Pajvanl UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003;278:9073-9085.
34. Park YW, Zhu S, Palaniappan L et al. The metabolic syndrome: prevalence and associated risk factor findings In the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
35. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-981.
36. Swarbrick MM, Austrheim-Smith IT, Stanhope KL et al. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia 2006;49:2552-2558.
37. Hara, K, Horikoshi M, Yamauchi T et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29:1357-1362.
38. Nakashima R, Kamel N, Yamane K et al. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006;91:3873-3877.
39. Retnakaran R, Hanley AJ, Connelly PW et al. Low serum levels of high-molecular weight adiponectin in Indo-Asian women during pregnancy: evidence of ethnic variation in adiponectin isoform distribution. Diabetes Care 2006;29:1377-1379.
40. Kadowaki T, Yamauchi T, Kubota N et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-1792.
41. Park KG, Park KS, Kim MJ et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-142.
42. Tschritter O, Fritsche A, Thamer C et al. Plasma adiponectn concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-243.